Recurrent Gastric Cancer Completed Phase 2 Trials for Lapatinib (DB01259)

Also known as: Gastric cancer recurrent / Stomach cancer recurrent / Stomach carcinoma recurrent / Gastric carcinoma recurrent

IndicationStatusPhase
DBCOND0028800 (Recurrent Gastric Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00103324S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach CancerTreatment